Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116909) titled 'To study drug interaction between Griseofulvin, a commonly used Antifungal medicine, and Artemether-Lumefantrine, a well known Antimalarial medicine' on Sept. 2.

Study Type: Interventional

Study Design: Randomized, Crossover Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:An Open list of random numbers Blinding and masking:Open Label

Primary Sponsor: BRIC Institute of Life Sciences

Intervention: Intervention1: Artemether/Lumefantrine, griseofulvin combination: Single dose 80/480 mg and 500 mg tablets will be administered orally Inter...